View text source at Wikipedia

Indanorex

Indanorex
Clinical data
ATC code
  • none
Identifiers
  • 2-(1-Aminopropyl)indan-2-ol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H17NO
Molar mass191.274 g·mol−1
3D model (JSmol)
  • OC2(Cc1ccccc1C2)C(N)CC
  • InChI=1S/C12H17NO/c1-2-11(13)12(14)7-9-5-3-4-6-10(9)8-12/h3-6,11,14H,2,7-8,13H2,1H3 checkY
  • Key:QTZFSVVIXMRRLW-UHFFFAOYSA-N checkY
  (verify)

Indanorex (Dietor) is a stimulant drug which was developed in the 1970s.[1][2] It has appetite suppressant effects[medical citation needed] and also has antihypoglycemia effects.[3]

A chemical synthesis has been reported.[4]

See also

[edit]

References

[edit]
  1. ^ Jacques Georges Maillard, U.S. patent 3,885,045 (1975 to Logeais Labor Jacques).
  2. ^ FR 2322851  (1977 to Logeais Labor Jacques).
  3. ^ Giugliano D, Luyckx A, Binder D, Lefebvre P (February 1979). "Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia". International Journal of Clinical Pharmacology and Biopharmacy. 17 (2): 76–81. PMID 422305.
  4. ^ Maillard, J. et al, Bull. Soc. Chim. Fr., 1967, 2110.


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.